Creative Medical TechnologyCELZ
13F holders, Q3 2024 (September 30)10holders +1
1new positions
0sold out
$3.09avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Creative Medical Technology (CELZ) in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were Aaron Wealth Advisors LLC ($61K), Vanguard Group Inc. ($54K) and Two Sigma Advisers, LP ($45K).
- Company
- Creative Medical Technology
- CUSIP
- 22529Y408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $8K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 2,727 shares bought and 2,899 shares sold, net −172 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Aaron Wealth Advisors LLC | 0.01% | No change | 19,570 | $61K |
| Vanguard Group Inc. | 0.00% | No change | 17,629 | $54K |
| Two Sigma Advisers, LP | 0.00% | Reduce -3.3% | 14,500 | $45K |
| Two Sigma Investments, LP | 0.00% | Reduce -11.5% | 13,106 | $41K |
| UBS Group AG | 0.00% | New | 2,725 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -33.2% | 1,403 | $4K |
| Bank of America Corp. | 0.00% | Add +1.6% | 131 | $406 |
| Osaic Holdings, Inc. | 0.00% | No change | 101 | $313 |
| Morgan Stanley | 0.00% | No change | 20 | $62 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is CELZ's weight in each manager's 13F, not the share of Creative Medical Technology the manager owns.